PharmaVOICE Blog Post

Clinical Trial Simulation (CTS) in Early Market Access Planning

Posted By: Dan Limbach
November 5, 2018

In this white paper, you will learn how clinical trial simulation (CTS) can support early market access planning by predicting a range of feasible trial results of a new treatment that can be fed into an economic model, making it possible to anticipate challenges to the economic value story. By understanding these challenges at the trial design phase, adjustments to the trial protocol and preparations for additional evidence generation can be made to improve the chances for a successful launch.

Download the full white paper – instant pdf download.

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.